Registry Study of COAGADEX® Patients With Moderate or Severe Hereditary Factor X Deficiency Undergoing Major Surgery

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 27, 2018

Primary Completion Date

October 13, 2021

Study Completion Date

October 13, 2021

Conditions

Factor 10 Deficiency

Interventions

DRUG

Coagadex

Plasma-driven blood coagulation factor X concentration

Trial Locations (3)

University of Florida Health, Gainesville

West Michigan Cancer Center, Kalamazoo

Tulane University Hospitals and Clinics, New Orleans